admelog
Generic: insulin lispro
Labeler: sanofi-aventis u.s. llcDrug Facts
Product Profile
Brand Name
admelog
Generic Name
insulin lispro
Labeler
sanofi-aventis u.s. llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
insulin lispro 100 U/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0024-5926
Product ID
0024-5926_9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA209196
Listing Expiration
2026-12-31
Marketing Start
2018-10-19
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00245926
Hyphenated Format
0024-5926
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
admelog (source: ndc)
Generic Name
insulin lispro (source: ndc)
Application Number
BLA209196 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 U/mL
Packaging
- 1 VIAL in 1 CARTON (0024-5926-05) / 3 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5", "openfda": {"nui": ["N0000004931", "N0000175453"], "unii": ["GFX7QIS1II"], "rxcui": ["242120", "1652639", "1992169", "1992171"], "spl_set_id": ["0691def8-4a7b-4de3-866f-a280989f47f1"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Sanofi-Aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0024-5926-05) / 3 mL in 1 VIAL", "package_ndc": "0024-5926-05", "marketing_start_date": "20181019"}], "brand_name": "ADMELOG", "product_id": "0024-5926_9631cc90-ea8d-42bb-ba01-ed8f09b8a6c5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [Chemical/Ingredient]"], "product_ndc": "0024-5926", "generic_name": "insulin lispro", "labeler_name": "Sanofi-Aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADMELOG", "active_ingredients": [{"name": "INSULIN LISPRO", "strength": "100 U/mL"}], "application_number": "BLA209196", "marketing_category": "BLA", "marketing_start_date": "20181019", "listing_expiration_date": "20261231"}